Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Flk-1 Rat anti-Mouse, PerCP-Cy5.5, Clone: AVAS 12A1, BD

Rat Monoclonal Antibody

Supplier:  BD Biosciences 560681

Catalog No. BDB560681


Only null left
Add to Cart

Description

Description

The Avas 12α1 antibody reacts with fetal liver kinase 1 (Flk-1), a receptor protein tyrosine kinase closely related to CD117 (c-kit) and CD140a (PDGF Receptor α chain) of the immunoglobulin superfamily. Flk-1, also known as VEGF Receptor-2 (VEGF-R2), is a receptor for vascular endothelial growth factor (VEGF). It is expressed, at the mRNA and protein levels, on distinct sets of mesoderm during gastrulation and on endothelial cells in embryonic tissues. In vivo and in vitro studies indicate that Flk-1 is required for the embryonic development of vascular endothelial and hematopoietic cells.

Flow Cytometry, Intracellular Staining

TRUSTED_SUSTAINABILITY
Specifications

Specifications

Flk-1
Monoclonal
0.2mg/mL
Fetal liver kinase 1; CD309; Kdr; VEGF receptor-2; VEGFR-2
Rat
Affinity Purified
RUO
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Flow Cytometry
AVAS 12A1
PerCP-Cyanine5.5
Aqueous buffered solution containing ≤0.09% sodium azide.
Mouse Flk1 and human IgG1 fusion protein
50 μg
Immunology
Mouse
IgG2a κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.